Ohio federal prosecutors collected a record $133 million this year from criminal and civil settlements, with a $109 million Christ Hospital settlement comprising the majority of this year's record, according to a news report by the Enquirer.
The Latest
Three bills have been proposed in New Jersey which could benefit ambulatory surgery centers, according to Jeffrey Shanton, chair, Advocacy and Legislative Affairs Committee, New Jersey Association of Ambulatory Surgery Centers.
Northstar Healthcare, an owner and manager of ambulatory surgery centers, has announced the syndication of its newly formed operating partnership MicroSurgery Institute (MSI) of Houston.
Gastroenterologist Seth A. Gross, MD, and general surgeon Neil Floch, MD, are now performing Transoral Incisionless Fundoplication for the treatment of gastroesophageal reflux disease at Norwalk (Conn.) Hospital, according to a news release from the hospital.
Demonstration RACs have identified two high-risk vulnerabilities for physician claims leading to denials, according to an MLN Matters article from CMS.
The use of techniques such as radiotherapy and radionuclides, as well as short-onset drugs, may be useful in decreasing pain flares, according to a study by Italian expert Professor Sebastiano Mercadante.
Timely and accurate completion of medical records is essential to ensuring great quality of care, as even the smallest inconsistency or miscommunication of patient information could mean negative consequences for the patient. Here are three ways ASCs can ensure medical…
Serbin Surgery Center Billing and Short Hills Surgery Center recently presented a free webinar entitled, "Hybrid Center – The Best of Both Worlds (How to Successfully Combine In-Network and Out-of-Network Reimbursement)."
CMS hopes Medicare beneficiaries in nine metropolitan statistical areas (MSAs) will start to see savings of up to more than 30 percent on certain durable medical equipment, prosthetics, orthotics and supplies beginning Jan. 1, 2011, as Medicare's Competitive Bidding Program…
King Pharmaceuticals and partner Acura Pharmaceuticals recently announced the submission of a new drug application for their opioid candidate, Acurox, according to a Zacks Investment Research report.